Universitätsklinikum Münster

Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea (2022) Allard P, Alhaj N, Lobitz S, Cario H, Jarisch A, Grosse R, Oevermann L, et al. Journal article Key characteristics impacting survival of COVID-19 extracorporeal membrane oxygenation (2022) Herrmann J, Lotz C, Karagiannidis C, Weber-Carstens S, Kluge S, Putensen C, Wehrfritz A, et al. Journal article (1 -> 3)-beta-D-Glucan-guided antifungal therapy in adults with sepsis: the CandiSep randomized clinical trial (2022) Bloos F, Held J, Kluge S, Simon P, Kogelmann K, De Heer G, Kuhn SO, et al. Journal article BASELINE CLINICAL DISEASE ACTIVITY IS NOT CRITICAL FOR PREDICTING REMISSION OF ADULTS ONSET STILL'S DISEASE (2022) Groetsch J, Tascilar K, Schett G, Foell D, Rech J Conference contribution RHABDOID TUMOR PREDISPOSITION SYNDROME (RTPS) - FINDING EVIDENCE BY SYSTEMATIC ANALYSES (2022) Nemes K, Bens S, Johann PD, Steinbuegl M, Gruhle M, Kachanov D, Teleshova M, et al. Conference contribution INFANTS AND NEWBORNS WITH ATYPICAL TERATOID/RHABDOID TUMORS (ATRT) AND EXTRACRANIAL MALIGNANT RHABDOID TUMORS: A UNIQUE AND CHALLENGING POPULATION (2022) Nemes K, Johann PD, Steinbuegl M, Gruhle M, Bens S, Kachanov D, Teleshova M, et al. Conference contribution Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations (2022) Eckardt JN, Stoelzel F, Kunadt D, Roellig C, Stasik S, Wagenfuehr L, Joehrens K, et al. Journal article Infants and Newborns with Atypical Teratoid Rhabdoid Tumors (ATRT) and Extracranial Malignant Rhabdoid Tumors (eMRT) in the EU-RHAB Registry: A Unique and Challenging Population (2022) Nemes K, Johann PD, Steinbügl M, Gruhle M, Bens S, Kachanov D, Teleshova M, et al. Journal article Contact sensitization to essential oils: IVDK data of the years 2010–2019 (2022) Geier J, Schubert S, Reich K, Skudlik C, Ballmer-Weber B, Brehler R, Weisshaar E, Uter W Journal article High-Dose Treosulfan and Melphalan as Consolidation Therapy Versus Standard Therapy for High-Risk (Metastatic) Ewing Sarcoma (2022) Koch R, Gelderblom H, Haveman L, Brichard B, Jürgens H, Cyprova S, Van Den Berg H, et al. Journal article